News | September 24, 2025
Dr. Reddy's receives positive CHMP opinion from EMA for denosumab 'AVT03'
Prolia is a prescription medicine used to treat osteoporosis in women
Prolia is a prescription medicine used to treat osteoporosis in women
Emcure Pharmaceuticals successfully completes USFDA PAI of Oncology facility
Vevzuo is authorized for the prevention of skeletal related events in adults with advanced malignancies involving bone
The companies admitted taking part in the cartel in exchange for reduced fines but Alchem did not settle
YESINTEK is indicated for the treatment of adults and children from the age of 6 years and olde
Dr. Reddy's had previously received the EU GMP certificate for its Rituximab drug substance
The centralized marketing authorization granted by the EC is valid in all EU Member States as well as in the European Economic Area (EEA) countries Iceland, Liechtenstein and Norway
Myovant to receive an upfront payment of US $50 million, is eligible to receive commercial launch, sales-based and other milestones totaling up to US $90.5 million
If approved, PreHevbri will be the only approved 3-antigen hepatitis B vaccine for adults in the E.U.
Tepmetko is the first and only oral MET inhibitor to be approved in the European Economic Area for treating adult patients with advanced NSCLC harboring alterations leading to METex14 skipping, who require systemic therapy following prior treatment
Subscribe To Our Newsletter & Stay Updated
